Journal of Oleo Science
Online ISSN : 1347-3352
Print ISSN : 1345-8957
ISSN-L : 1345-8957
Detergents, Surfactants, Interface and Colloid
A Novel Lid Hygiene Detergent Successfully Eliminated Demodex Mites, a Common Pathogen of Refractory Obstructive Meibomian Gland Dysfunction
Hirotaka Tanabe, Shigeru Nakamura, Motoko Kawashima, Reiko Ishida, Minako Kaido, Miki Mizuno, Enrique A. Sato, Sachiko Inoue, Masahiko Ayaki, Kazuo Tsubota
Author information
JOURNAL OPEN ACCESS
J-STAGE Data Supplementary material

2021 Volume 70 Issue 6 Pages 799-805

Details
Abstract

Introduction: Demodex mites are microscopic arthropods that have been shown to be responsible for chronic blepharitis. Although many reports have demonstrated positive effects of lid hygiene on demodicosis, some have produced conflicting results. We retrospectively evaluated the effect of lid margin cleansing with a novel lid hygiene detergent, Eye Shampoo, in patients with ocular demodicosis. Methods: Outpatient clinic notes recorded over a 24-month period between June 30, 2016, and June 29, 2018, at Keio University Hospital in Japan were reviewed to identify patients diagnosed with ocular demodicosis who started cleansing their lid margins with Eye Shampoo at least once daily as a lid hygiene therapy. Results: Five patients diagnosed with ocular demodicosis who started cleansing their lid margins using Eye Shampoo for lid hygiene were identified. In four cases, Demodex mites were successfully eliminated, and ocular conditions were ultimately improved with no recurrence. Active Demodex mites were still noted after 3 months of lid hygiene therapy in one case; further observation of this case was not available. There were no adverse effects of Eye Shampoo in any of these cases. Conclusion: Lid hygiene therapy using Eye Shampoo successfully eliminated Demodex mites, a common pathogen of refractory obstructive meibomian gland dysfunction.

graphical abstract Fullsize Image
Content from these authors
© 2021 by Japan Oil Chemists' Society

This article is licensed under a Creative Commons [Attribution-ShareAlike 4.0 International] license.
https://creativecommons.org/licenses/by-sa/4.0/
Previous article Next article
feedback
Top